ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ICON plc (NASDAQ: ICLR), a leading healthcare intelligence and clinical research organisation, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Dr. Steve Cutler, CEO of ICON plc, is scheduled to present at the conference on Tuesday, January 14, 2025 at 3:45pm PST. The company will provide updates regarding any changes to the event and access to the live webcast through the Investor section of their website under the Events tab.
ICON plc (NASDAQ: ICLR), un'organizzazione leader nel campo dell'intelligenza sanitaria e della ricerca clinica, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. Dr. Steve Cutler, CEO di ICON plc, è programmato per presentare alla conferenza il martedì 14 gennaio 2025 alle 15:45 PST. L'azienda fornirà aggiornamenti riguardo eventuali cambiamenti all'evento e l'accesso alla diretta streaming attraverso la sezione Investitori del loro sito web sotto la scheda Eventi.
ICON plc (NASDAQ: ICLR), una organización líder en inteligencia sanitaria e investigación clínica, ha anunciado su participación en la 43ª Conferencia Anual J.P. Morgan Healthcare. Dr. Steve Cutler, CEO de ICON plc, está programado para presentar en la conferencia el martes 14 de enero de 2025 a las 3:45 p.m. PST. La empresa proporcionará actualizaciones sobre cualquier cambio en el evento y acceso a la transmisión en vivo a través de la sección de Inversores en su sitio web bajo la pestaña de Eventos.
ICON plc (NASDAQ: ICLR)는 의료 정보 및 임상 연구 분야의 선도적인 조직으로, 제43회 JP모건 헬스케어 컨퍼런스에 참가한다고 발표했습니다. Dr. Steve Cutler, ICON plc의 CEO는 2025년 1월 14일 화요일 오후 3시 45분 PST에 컨퍼런스에서 발표할 예정입니다. 회사는 이벤트에 대한 변경 사항과 이벤트 탭 아래 투자자 섹션을 통한 라이브 웹캐스트 액세스를 제공할 것입니다.
ICON plc (NASDAQ: ICLR), une organisation de premier plan dans le domaine de l'intelligence sanitaire et de la recherche clinique, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. Dr. Steve Cutler, PDG d'ICON plc, est prévu pour présenter à la conférence le mardi 14 janvier 2025 à 15h45 PST. L'entreprise fournira des mises à jour concernant tout changement de l'événement et l'accès au webinaire en direct via la section Investisseurs de leur site web sous l'onglet Événements.
ICON plc (NASDAQ: ICLR), ein führendes Unternehmen im Bereich Gesundheitsintelligenz und klinische Forschung, hat die Teilnahme an der 43. J.P. Morgan Healthcare-Konferenz bekannt gegeben. Dr. Steve Cutler, CEO von ICON plc, wird am Dienstag, den 14. Januar 2025, um 15:45 Uhr PST auf der Konferenz präsentieren. Das Unternehmen wird Updates zu eventuellen Änderungen der Veranstaltung und Zugang zum Live-Webcast über den Investorenbereich ihrer Website unter dem Reiter Veranstaltungen bereitstellen.
- None.
- None.
Any changes to this event and links to the live webcast will be posted on the Investor section of our website under “Events”.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in
This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.
ICON/ICLR-G
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107693288/en/
Kate Haven Vice President Investor Relations +1888 381 7923
Source: ICON plc
FAQ
When is ICON plc (ICLR) presenting at the 2025 J.P. Morgan Healthcare Conference?
Who will represent ICON plc (ICLR) at the 2025 J.P. Morgan Healthcare Conference?
How can investors access ICON plc's (ICLR) presentation at the J.P. Morgan Healthcare Conference?
Which annual J.P. Morgan Healthcare Conference will ICON plc (ICLR) be presenting at?
